Funding Opportunities
European Commission - Horizon 2020
Wallenberg Foundations
National Institutes of Health NIH
Research Professional
Anna Lobell - Krister Halldin - Anders Alderborn - Carolina Rydin - Sofia Wretblad - Ulrika Huss Melin
Swedish grants
• Government, private
• Centralized proposals
• Evaluations
Web
• Research Professional
• Call portal
• Manuals, forms
Research Officers
European Union
• Identify calls
• Proposal, negotiation
• Implementation
Research Officers
Financial Unit
EU Research Officers
Financial Issues
• Budget calculation
• Financial reporting
• Audit
UU ”Grants
Office”
Financial Unit
Legal Issues
• Contract
• IPR
• Copyright
Legal Unit
American grants
• NIH etc
• Proposals
• Reporting
Research Officers
Innovation & patent
• Patent
• Commersialisation
• Business collaborations
UU Innovation
Comparison of funding agencies
2013 Millions of SEK
4500
4000
3500
3000
2500
2000
1500
1000
500
0
Årsrapport 2014 UKÄ
Income MedFarm 2010-12 (tkr)
ongoing and new contracts
Agency (sorted on size 2012)
2010
2011
2012
140 232
151 413
167 099
Cancerfonden
52 801
57 843
51 694
EU (FP7, exkl ERC)
18 025
31 044
44 967
Formas
17 669
23 415
35 301
K&A Wallenberg Stiftelse
27 586
23 236
25 192
Vinnova
38 285
22 718
24 386
0
0
23 755
SIDA
19 765
18 591
19 378
SSF
22 069
22 359
21 023
4 353
10 257
12 454
FAS
11 740
6 019
8 880
Others (privata stiftelser o fonder, amerikanska, företag mm)
145939
169588
158976
Totalt
498455
536482
593105
Vetenskapsrådet
ERC (FP7)
Uppsala Akademiförvaltning
4
EU Framework Programmes
• To strengthen European competitiveness,
economic growth and employment
• Based on “Knowledge Triangle”
• Programmes:
FP1 to FP7, 1984 – 2013
Horizon 2020, 2014 – 2020
Research & Technology
Knowledge
triangle
Education
Innovation
Main goals
1. Strengthen the EU’s position in science
– Boost top-level research
2. Strengthen European industry, in particular small companies
(SMEs)
– Greater access to capital and support for SMEs
– Remove obstacles in industrial innovation
3. Address major European concerns (“societal challenges”)
– Health problems, aging population, food safety, environment etc
– Bridge the gap between research, healthcare and market
2014-2020, €80 billion
39%
3. Societal Challenges
32%
1. Excellent Science
2. Industrial leadership
HORIZON 2020
21%
•
•
•
•
European Research Council
Marie Skłodowska-Curie Actions
Future and Emerging Technologies
Research Infrastructures
• Health, demographic change and well-being
• Food security, sustainable agriculture and forestry,
marine and maritime and inland water research, and
the bioeconomy
• Secure, clean and efficient energy
• Smart, green and integrated transport
• Climate action, environment, resource efficiency and
raw materials
• Europe in a changing world - inclusive, innovative and
reflective societies
• Secure societies - protecting freedom and security of
Europe and its citizens
3. Societal Challenges
1. Excellent Science
2. Industrial leadership
HORIZON 2020
• Enabling and industrial
technologies
• Innovation in SME
• Access to Risk Finance
Prio 1 - Excellent Science
• European Research Council (ERC)
• Marie Skłodowska-Curie Actions (MSCA)
• Future and Emerging Technologies (FET)
• Research Infrastructures (RI)
ERC (European Research Council)
• Basic frontier research, “bottom-up” (like VR)
• Project types:
1.
Starting Grant
2-7 years from dissertation, ≤1.5 M€ over 5 years
2.
Consolidator Grant
8-12 years from dissertation, ≤2 M€ over 5 years
3.
Advanced Grant
≤2,5 (3,5) M€ over 5 years
4.
Synergy Grant
2 - 4 researchers, ≤15 M€ over 5 years
5.
Proof of Concept
≤150 k€ over 1 year
Bridge gap between research and a marketable innovation
Can be used as recruitment instrument from any country
ERC (European Research Council)
• Basic frontier research, “bottom-up” (like VR)
• Project types:
1.
Starting Grant
2-7 years from dissertation, ≤1.5 M€ over 5 years
2.
Consolidator Grant
8-12 years from dissertation, ≤2 M€ over 5 years
3.
Advanced Grant
≤2,5 (3,5) M€ over 5 years
4.
Proof of Concept Grant
≤150 k€ over 1 year
For ERC Grant holders to investigate innovation potential
Can be used as recruitment instrument from any country
Marie Skłodowska-Curie Actions
(People in FP7)
• Education, career development for researchers
• Mobility within, to and outside Europe
• Broadened interaction between industry and academia
Bottom-up programmes
Marie Skłodowska-Curie Actions
• IF – Individual Fellowships
– Research in an (another) EU country (1-2 years)
– Research outside EU (1-2 years) and within EU again (1 year)
Researcher
• ITN – Innovative Training Networks
– European “Research Training school” (5 – 10 partners) - ETN
– Joint doctorate between Universities - EJD
– Industry doctorate (in conjunction with university) - EID
• RISE – Research and Innovation Staff Exchange
– Knowledge exchange by two-way secondments
Can be used as recruitment instrument from any country
PhD stud,
Researcher
PhD stud,
Researcher,
Lab staff
Future Emerging Technologies (FET)
• Collaborative research to support radically new technological
possibilities to “shape the future technology landscape”
• Three lines:
FET Open
FET Proactive
FET Flagships
Early-stage, visionary new
ideas
(bottom-up)
Based on challenges
Large-scale initiatives in
areas of European interest
(top-down)
Infrastructures
• Create and coordinate European facilities, resources
and services for research and innovation, e.g.
– Equipment, biobanks, databases
• Single site, distributed or virtual
• Based on ESFRI roadmap
Top-down programme
ESFRI = European Strategy Forum on Research Infrastructures
Prio 2 – Industrial leadership
• Leadership in enabling and industrial
technologies
• Innovation in SME
• Access to Risk Finance
Leadership in enabling and
industrial technologies
• Collaborative projects to build industrial leadership
within prioritized areas:
–
–
–
–
–
–
ICT (Information and Communication Technologies)
Nanotechnologies
Advanced materials
Biotechnology
Advanced manufacturing and processing
Space
• Bridge the gap between research and marketable
products and services
Top-down programme (needs in industry)
Innovation in SME
• Funding to SMEs, entrepreneur coaching, IPR helpdesk etc
May involve collaboration with University
Access to Risk Finance
• Loans, risk finance, bank guarantees to companies
Prio 3 – Societal challenges
• Health, demographic change and well-being
• Food security, sustainable agriculture and forestry,
marine and maritime and inland water research, and the
bioeconomy
• Secure, clean and efficient energy
• Smart, green and integrated transport
• Climate action, environment, resource efficiency and raw
materials
• Europe in a changing world - inclusive, innovative and
reflective societies
• Secure societies - protecting freedom and security of
Europe and its citizens
Funding schemes
• Research and Innovation Action
• Coordination and support
– E.g. networking, support services, standardisations
• Innovation Action
– Close-to-market research
• SME instrument
– Tailored support to SMEs to develop innovative ideas
• Fast track to innovation
– Short project to speed up time from idea to market
• Prizes
• ERA-NET
– Applied for by national funders
Research and Innovation Action
• Collaborations between academia, industry and healthcare
• ≥3 (often 5 – 15) partners from ≥3 countries
– Participate as coordinator or partner
• Project budget
≈2 – 6 M€ (20M€)
• Three evaluation criteria:
1.
2.
3.
Science
Impact
Implementation
”Top-down” program. SMEs often important
What is different from FP7?
• Health => Health, demography and wellbeing
• Broader topics => greater freedom to suggest
solutions
• More emphasis on bridging the gap between
academia, healthcare and market
– Open innovation
– Higher participation of industry, healthcare and authorities
– Clinical research more important
• Stronger emphasis on expected impact
– Correlate to EU strategies
Important with networking!
Funding rates
• 100% of direct costs
• 25% overhead
However, companies in Innovation actions:
• 70% of direct costs
• 25% OH
More Information
http://ec.europa.eu/research/participants/portal
25
•
•
•
•
European Research Council
Marie Skłodowska-Curie Actions
Future and Emerging Technologies
Research Infrastructures
• Health, demographic change and well-being
• Food security, sustainable agriculture and forestry,
marine and maritime and inland water research, and
the bioeconomy
• Secure, clean and efficient energy
• Smart, green and integrated transport
• Climate action, environment, resource efficiency and
raw materials
• Europe in a changing world - inclusive, innovative and
reflective societies
• Secure societies - protecting freedom and security of
Europe and its citizens
3. Societal Challenges
1. Excellent Science
COST
• Enabling and industrial
technologies
• Innovation in SME
• Access to Risk Finance
2. Industrial leadership
EIT European Institute of innovation & Technology
EuroStars 2
Partnership Programs, PPP, JPI, JTI (e.g. IMI 2)
JRC Joint Research Centre
HORIZON 2020
Innovative Medicines Initiative 2
(IMI 2)
• Cooperation between the commission and drug industry (via
EFPIA) = PPP
– Possibly extended into other areas of life science in IMI2
• “Pre-competitive” research for improved drugs
– E.g. clinical trial design, new antibiotics, common stem cell bank
• ≥3 (often 5 – 15) partners from ≥3 countries
www.imi.europa.eu
”Top-down” program
COST
• COST = Network projects within 36 COST countries
• Funding for project meetings, conferences, travel,
accommodation, (not research)
• Strengthen cooperation and defragmentation in Europe
• Capacity building by promoting early-career researchers
www.cost.eu
”Bottom-up” program
Upcoming deadlines
Program
Deadline
Personalising health and care
ERC Advanced Grant
IMI2 (T1DM therapy, macular degeneration and diabetic retinopathy)
Marie Curie ITN
ERC Starting Grant
Personalising health and care
ERC Consolidator Grant
October 14
October 21
November 12
January 13
February 3
February 24
March 12
Newsletter about upcoming calls
Anders Alderborn, PhD, Assoc Prof
Contact and support EU
anders.alderborn@uadm.uu.se
018 - 471 2577
070 - 425 0754
Krister Halldin, PhD
krister.halldin@uadm.uu.se
018 - 471 2587
070 - 425 0753
Anna Lobell, PhD, Assoc Prof
anna.lobell@uadm.uu.se
018 - 471 5086
070 - 425 0706
Offices at BMC, A2 floor 1
•
•
•
•
•
•
Find EU programme
Apply
Negotiate
Implement project
Report
Influence upcoming calls
https://mp.uu.se/web/info/forska/forskarservice
32
33
35
Note
• VR Grants for international recruitment of
leading researchers (<15 mkr/year, 10 years)
• VR International Career Grants, April X
• Wallenberg Academy Fellows, Jan X (Head of Dept nominates)
• Workshop for Young Researchers applying to VR
(start up seminar 3 Dec)
• FORTE – more focus on health/welfare issues
38
VR Medicin och hälsa 2013
Summa projektbidrag 2008 – 2013 (inkl. unga forskare) i kr
för hela anslagsperioden (3 – 6 år), de fem största lärosätena
600,000,000
500,000,000
400,000,000
KI kr
LU kr
300,000,000
GU kr
UU kr
UmU kr
200,000,000
100,000,000
0
2008
2009
2010
2011
2012
2013
VR MH 2013 – Projektbidrag (inkl. unga forskare), antal
ansökningar och antal beviljade (12 lärosäten)
600
500
Antal
400
300
200
100
0
KI
GU
LU
UU
UmU
LiU
SU
SLU
KTH
CTH
SLL
HiB
Beviljade Projekt
103
30
39
22
15
7
3
2
0
2
1
1
Ansökta Projekt
553
198
235
165
105
73
22
9
7
4
4
1
VR MH 2013 – Projektbidrag unga forskare, antal
ansökningar och antal beviljade (12 lärosäten)
180
160
140
Antal
120
100
80
60
40
20
0
KI
GU
LU
UU
UmU
LiU
SU
SLU
KTH
CTH
SLL
HiB
Beviljade Projekt-bidrag - Unga forskare
15
1
5
2
3
0
0
0
0
0
0
0
Ansökta Projektbidrag - Unga forskare
167
57
76
47
25
12
6
3
1
1
0
0
VR MH 2011-2013 Projektbidrag unga forskare (alla)
Antal beviljade
MH Unga forskare
Summa kronor
2011
2012
2013
KI
39
26
15
GU
14
9
1
34 800 000
43 400 000
10 000 000
LU
12
13
5
30 700 000
58 381 000
35 945 000
UU
6
3
2
13 800 000
11 050 000
11 950 000
UmU
7
2
3
16 350 000
7 324 000
18 544 000
LiU
2
2
4 800 000
6 650 000
SU
2
7 800 000
SLU
1
2 100 000
ÖU
1
1 800 000
Summa antal beviljade, summa belopp
84
55
26
2011
2012
2013
95 500 000 111 572 000 102 077 000
207 650 000 238 377 000 178 516 000
Contact and support
Carolina Rydin, PhD
carolina.rydin@uadm.uu.se
018 - 471 2578
0701 - 67 93 14
Sofia Wretblad, PhD
National funding bodies
- Centrally coordinated
applications
- Applications signed by the
Vice-Chancellor
sofia.wretblad@uadm.uu.se
018 - 471 7137
070 - 425 0412
Ulrika Huss Melin, PhD
ulrika.huss.melin@uadm.uu.se
018 - 471 1893
070 - 425 0188
Offices at St: Olofsgatan
The Wallenberg Foundations
(KAW, MMW, MAW)
US Funding Opportunities
(NIH, NSF, USAID etc)